Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated

Symptoms and Clinical Signs Across the Lifespan

At a Glance

Aromatase deficiency can cause different findings at different ages: maternal androgen symptoms and atypical genital development before birth, delayed puberty and ovarian cysts in 46,XX individuals, and tall stature, weak bones, or delayed bone age in 46,XY individuals.

Aromatase deficiency does not look the same for everyone. Because the condition affects how the body manages sex hormones from before birth through adulthood, the symptoms change depending on a person’s age and their chromosomal pattern (46,XX or 46,XY). This range of physical signs is known as the phenotypic spectrum [1]. Keep in mind that the condition is exceptionally rare; much of the evidence consists of case reports and small case series, so percentages and typical ages are possibilities, not fixed individual predictions.

Signs Before and At Birth

For many families, the first signs of aromatase deficiency appear before the baby is even born. Because the placenta cannot properly convert the baby’s androgens into estrogens, these androgens can cross back into the mother’s bloodstream [2].

  • Maternal Virilization: During pregnancy, a mother may suddenly develop symptoms typically associated with high androgens, such as severe acne, a deepening voice, or hirsutism (unusual hair growth on the face or body) [1]. While symptoms like acne or hair may improve shortly after the baby is born, voice deepening or other androgen effects can persist, and maternal androgen excess warrants careful medical evaluation [2].
  • Genital Appearance in 46,XX Infants: Most 46,XX infants with this condition are born with atypical genital development. This means the external genitals may not look clearly male or female. Doctors often use the Prader scale to describe this, with many aromatase-deficient infants falling into stages III or IV, where the features are more significantly virilized [1][3].

Presentation in 46,XX Individuals

As a child grows, the lack of estrogen and the buildup of other hormones create a specific pattern of symptoms:

  • Delayed Puberty: Puberty often does not start on its own. While some individuals may experience some breast development (thelarche), most face primary amenorrhea (the absence of a first menstrual period) [3][4].
  • Ovarian Cysts: In a review of reported cases, about 43% of 46,XX individuals developed large cysts on their ovaries [1]. These cysts can cause the ovaries to become very large and, in some cases, can lead to ovarian torsion—a medical emergency where the ovary twists on its blood supply, causing sudden, severe pain [5]. Ultrasound frequency is individualized.
  • Hormone Markers: Lab tests typically show very high levels of FSH (Follicle-Stimulating Hormone), as the brain tries unsuccessfully to signal the body to produce estrogen [3].

Presentation in 46,XY Individuals

In 46,XY individuals, the diagnosis is often missed in childhood because there are rarely any unusual signs at birth. Diagnosis often happens much later, sometimes not until a person is in their 20s or 30s [6].

  • Prolonged Growth: Without estrogen to “close” the epiphyses (the growth plates at the ends of bones), the growth plates may remain open longer than expected. This can lead to tall stature and relatively long arms and legs [7][8].
  • Bone Health: Estrogen is vital for bone strength in all bodies. Individuals with this condition often experience early-onset osteoporosis or osteopenia (thinning bones), which can lead to easy fractures [9][10]. Some case reports note bone pain or leg cramps, but this is a variable finding.
  • Delayed Bone Age: X-rays often show that the bones appear much “younger” than the person’s actual age because the growth plates remain open [7].

Metabolic and Lifestyle Factors

While not every patient experiences them, some metabolic differences have been linked to aromatase deficiency in small case series. Estrogen plays a role in how the body processes fats and sugars [9].

  • Insulin Resistance: Some patients may have higher-than-normal blood sugar or insulin levels, which can increase the risk of Type 2 diabetes over time [11].
  • Lipid Changes: Changes in cholesterol or triglyceride levels (dyslipidemia) can occur, though some studies have shown patients with normal profiles [1][9].
  • Weight Management: While some reports mention weight gain or a higher body mass index, this is not a universal symptom; some individuals with the condition maintain a typical weight [9].

Because this condition is so rare, your specific “mix” of symptoms might be unique. Regular individualized monitoring of bone health and hormone levels by a specialist is the standard way to manage this broad spectrum of physical signs.

Common questions in this guide

What signs can aromatase deficiency cause before or at birth?
A mother carrying an affected pregnancy may develop androgen-related acne, facial or body hair growth, or a deeper voice because androgens can enter her bloodstream. A 46,XX infant may be born with atypical genital development, while a 46,XY infant may have no obvious genital differences at birth.
How can aromatase deficiency affect puberty and menstruation?
Puberty may not begin on its own. In 46,XX individuals, breast development may be limited or variable and most have primary amenorrhea, meaning they do not have a first menstrual period. 46,XY individuals may be diagnosed later, sometimes in adulthood, because childhood signs can be subtle.
Are ovarian cysts common in 46,XX aromatase deficiency?
In a review of reported cases, about 43% of 46,XX individuals developed large ovarian cysts, although this estimate comes from rare case reports and may not predict an individual’s risk. A cyst can contribute to ovarian torsion, which causes sudden severe pain and needs urgent medical assessment. Ultrasound monitoring should be individualized by a clinician.
How does aromatase deficiency affect bone growth and strength?
Low estrogen can keep growth plates open longer, leading to tall stature, relatively long arms and legs, and delayed bone age. It can also cause early osteopenia or osteoporosis, which increases fracture risk; some people report bone pain or leg cramps.
Can aromatase deficiency cause metabolic problems?
Some reported patients have insulin resistance, higher blood sugar or insulin levels, or changes in cholesterol and triglycerides. Weight gain and a higher body mass index have also been reported, but metabolic findings are variable and some people have normal weight and lipid profiles.
How is aromatase deficiency recognized or evaluated?
Evaluation may combine the person’s chromosomal pattern and clinical findings with hormone tests and imaging. In 46,XX individuals, very high follicle-stimulating hormone, or FSH, can reflect the body’s unsuccessful attempt to stimulate estrogen production; X-rays may show delayed bone age when growth plates remain open.

Get notified when new evidence is published on Aromatase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Aromatase deficiency: A case series of 46, XX Chinese children and a systematic review of the literature.

    Fan L, Zhang B, Li L, Gong C

    Clinical endocrinology 2020; (93(6)):687-695 doi:10.1111/cen.14277.

    PMID: 32623730
  2. 2

    Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the CYP19A1 Gene

    Özen S, Atik T, Korkmaz Ö, et al.

    Journal of clinical research in pediatric endocrinology 2020; (12(1)):109-112 doi:10.4274/jcrpe.galenos.2019.2018.0198.

    PMID: 30968679
  3. 3

    46,XX aromatase deficiency: A single-center experience with the varied spectrum and recurrent variants, and a systematic review of hormonal parameters.

    Yami Channaiah C, Memon SS, Sarathi V, et al.

    Annales d'endocrinologie 2024; (85(1)):48-55 doi:10.1016/j.ando.2023.05.010.

    PMID: 37348676
  4. 4

    An Intron 9 CYP19 Gene Variant (IVS9+5G>A), Present in an Aromatase-Deficient Girl, Affects Normal Splicing and Is Also Present in Normal Human Steroidogenic Tissues.

    Saraco N, Nesi-Franca S, Sainz R, et al.

    Hormone research in paediatrics 2015; (84(4)):275-82 doi:10.1159/000437142.

    PMID: 26279340
  5. 5

    Novel CYP19A1 Mutations Extend the Genotype-Phenotype Correlation and Reveal the Impact on Ovarian Function.

    Praveen VP, Ladjouze A, Sauter KS, et al.

    Journal of the Endocrine Society 2020; (4(4)):bvaa030 doi:10.1210/jendso/bvaa030.

    PMID: 32318648
  6. 6

    Bone Disease Associated with Inactivating Aromatase Mutations and its Management.

    Cavati G, Merlotti D, Cardamone P, et al.

    Calcified tissue international 2025; (116(1)):14 doi:10.1007/s00223-024-01330-0.

    PMID: 39751875
  7. 7

    Aromatase enzyme deficiency in an adult male patient and the effects of estrogen replacement therapy: a rare cause of tall stature.

    Imre E, Akçay S, Yavuz DG

    Hormones (Athens, Greece) 2025; (24(2)):525-532 doi:10.1007/s42000-025-00640-8.

    PMID: 40048086
  8. 8

    Aromatase deficiency caused by mutation of CYP19A1 gene: A case report.

    Li H, Fu S, Dai R, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2022; (47(6)):794-800 doi:10.11817/j.issn.1672-7347.2022.210401.

    PMID: 35837780
  9. 9

    Aromatase deficiency in a male patient - Case report and review of the literature.

    Miedlich SU, Karamooz N, Hammes SR

    Bone 2016; (93()):181-186 doi:10.1016/j.bone.2016.09.024.

    PMID: 27693882
  10. 10

    Aromatase mutation in men as a rare cause of osteoporosis: a case report and review of the literature.

    Stumper NA, Wientgen H, Al-Hashimi L, et al.

    Clinical and experimental rheumatology 2023; (41(7)):1434-1442 doi:10.55563/clinexprheumatol/gj7xal.

    PMID: 36622109
  11. 11

    Late Recognition of Aromatase Deficiency Following 16 Years of Misdiagnosis as Congenital Adrenal Hyperplasia: A Case with Coexisting Gonadoblastoma and Dysgerminoma.

    Alfadhli E, Turkistani A

    Journal of clinical research in pediatric endocrinology 2026; doi:10.4274/jcrpe.galenos.2026.2026-6-8.

    PMID: 42678028

This page is for informational purposes only and does not constitute medical advice about aromatase deficiency. A qualified clinician should interpret symptoms, hormone results, imaging, and monitoring needs for your specific situation.